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1. INTRODUCTION 
Local anesthetics are drugs which block impulse 
conduction in nerves. They prevent the influx of 
Na+ [1,2] by altering the increase in sodium per- 
meability associated with the generation of action 
potentials. Despite the numerous efforts to eluci- 
date the mechanism of local anesthetic action (cita- 
tions in [3]), the literature on this subject is still con- 
fused. Controversies persist over the specific sites 
on which local anesthetics act. The difficulties are 
mainly due to the requirement of high concen- 
trations so that the specificity can hardly be assess- 
ed. There are three main hypotheses to explain the 
blocking mechanism exerted by local anesthetics: 
(i) Non-specific actions, such as perturbation of 
protein structure [4] or membrane expansion 
]51; 
(ii) Changes in membrane surface charge [6,7]; 
(iii)Interaction with specific receptors [8,9]. 
Ion flux experiments using *Na+ have been 
proven a useful tool in studies of ionic channels 
(citations in [lo]). The voltage-dependent Na+ 
channel involved in the generation of action po- 
tential is also highly permeable to some other inor- 
ganic and organic cations, especially to guanidin- 
ium [ 1 I]. Thus [‘4C]guanidinium fluxes have been 
used to study the Na + channel in neuroblastoma 
cells [12]. In mouse neuroblastoma x rat glioma 
hybrid cells 113,141 guanidinium uptake has been 
stimulated by veratridine and aconitine (15,161, two 
alkaloids activating the action potential Na+ 
Abbreviation: ZC50: half-maximal inhibitory concen- 
tration 
Tetracaine Voltage-dependent sodium channel 
channel [ 171. This system has been used to charac- 
terize pharmacologically the action potential Na+ 
channel of the hybrid cells [ 15,16].These cells dis- 
play many characteristics of neurons [ 141. They are 
excitable upon electrical and chemical stimulation 
[14]. The inward current of their action potential 
can be carried either by Na+ or by Ca*+ [ 181. 
Here we report that various local anesthetic drugs 
affect the action potential Na+ channel of the hy- 
brid cells. The results show that dibucaine (ZC5u = 
0.1 mM), tetracaine (ZCsu = 0.2 mM), procaine 
(ZCsu = 0.8 mM), aminoacridine (ZCsu = 0.1 mM) 
and strychnine (ZC5u = 0.5-8 PM) inhibit the vera- 
tridine (or aconitine) -stimulated uptake of guani- 
dinium in the hybrid cells. Such studies of ion flux 
can easily give information about the relative po- 
tencies of the various local anesthetic drugs, which 
would be far more difficult to achieve in electro- 
physiological studies. 
2. MATERIALS AND METHODS 
Culturing of cells has been described 1141. Neu- 
roblastoma x glioma hybrid cells 108CC 15 [ 13,141 
or mouse neuroblastoma cells N lE-I 15 [ 191, in- 
itially seeded at 3.5 x IO5 cells/plate (60 mm diam.) 
were grown for 3 days. 
For measuring the uptake of guanidinium the 
growth medium was removed and 2 ml incubation 
medium added. The incubation medium consisted 
of 5.4 mM KCl, 1.8 mM CaC12, 1 mM MgC12,2.0 mM 
Na2HP04, 20 mM glucose, 20 mM N-2-hydroxy- 
ethyl-piperazine-N’-2-ethanesulfonic acid (adjust- 
ed to pH 7.4 with tris-(hydroxymethyl)- 
aminomethane), 145 mM NaCl or choline * Cl 
Published by Elsewer Biomedical Press 
00145793/82/0000-0000/$2.75 $1 1982 Federation of European Biochemical Societies 306 
Volume 143. number 2 FEBS LETTERS July 1982 
to keep the osmolarity at 320 mOsm/l. Together 
with 1 or 10 mM uanidinium - HCl (50-100 nCi 
= 1.8-3.7 kBq) [ t$ C]guanidinium/ml (Amersham 
Buchler, Braunschweig) were added. The uptake 
has been shown to be linear with time for 2 20 min. 
Therefore, the incubation carried out at 37°C 
usually was stopped after 10 min by aspirating 
the medium and subsequently washing the cells 
4 times with 3 ml ice-cold choline medium. The 
radioactivity retained in the cells was determined as 
in [15]. In parallel plates the protein content was 
measured using bovine serum albumin as a stan- 
dard [20]. 
Tetracaine l HCl (4-(butylamino)benzoic acid 
2-(dimethylamino)ethyl ester monohydrochloride), 
dibucaine l HCl(2-butoxy-N-[2-diethylamino) ethyl]- 
4-quinolinecarboxamide monohydrochloride), 
benzocaine (ethyl-p-aminobenzoate), veratridine, 
aconitine and scorpion toxin (from Leiurus quin- 
questriatus) were from Sigma, Munchen; procaine 
(2-(diethylamino)ethyl p-aminobenzoate) from 
Hoechst AG, Frankfurt; lidocaine (2-diethylamino- 
N-(2,6_dimethylphenyl)acetamide) from Roth, 
Karlsruhe; 9-aminoacridine l HCl from EGA- 
Chemie, Steinheim; strychnine l sulfate from 
Merck, Darmstadt. 
3. RESULTS 
There is a great variation in the potency at which 
local anesthetics could inhibit the entry of guanidin- 
ium ions through the veratridine-activated ion 
channel in neuroblastoma x glioma hybrid cells 
(tig.1). Under the experimental conditions the vera- 
tridine-activated ion channel is most likely iden- 
tical with the voltage-dependent sodium channel 
[ 15,161. Half-maximal inhibition of guanidinium 
uptake (ZC5u) was observed at 0.1 mM for both 
dibucaine and aminoacridine, at 0.2 mM tetracaine 
and at 0.8 mM procaine. The value for procaine was 
estimated on the basis of the assumption that the 
same maximal inhibition would be obtained as with 
the other compounds. Lidocaine and benzocaine 
had no significant effect at < 1 mM. The local an- 
esthetics similarly affected the basal uptake of 
guanidinium (legend to fig.1). Like the veratridine- 
stimulated guanidinium uptake, the veratridine- 
activated Li+ uptake in the hybrid cells, char- 
acterized in 1211, was inhibited by procaine (not 
shown). 
Veratridine added with scorpion toxin stimulates 
the uptake of guanidinium more prominently than 
veratridine alone (fig.2). This enhanced stimulation 
probably resulting from a synergistic activation of 
sodium channels by veratridine and scorpion toxin 
1171, was inhibited by local anesthetics (tig.2). Di- 
bucaine displayed the most potent inhibitory effect. 
For tetracaine the half-maximal inhibition was ob- 
served at 30 PM (not shown). 
Similar experiments were done using neuroblas- 
toma cells NlE-115 [ 191 (not shown). As in the hy- 
brid cells, the veratridine-stimulated uptake of 
guanidinium was inhibited by the local anesthetics 
described here. The most potent substance was 
benzocarne 
lidocaine 
orocame 
tetracaine 
aminoacridine 
dibucame 
b 
2 
e 0 1 
a0 5 L 3 2 
-log ([ local Mesthetic~(mol~l-ll~ 
Fig. 1. Rate of veratridine-activated guanidinium uptake 
in hybrid cells as a function of the concentration of var- 
ious local anesthetics. The points designated with ‘0”’ and 
‘cant 37”’ represent he control values for uptake at 0°C 
and 37”C, respectively, in the absence of any drug. The 
results are representative for 4 similar expt. For the for- 
mulae of the local anesthetics ee tig.2. The values for 
basal uptake of guanidinium at 37°C in the presence of 
1 mM of the following local anesthetics were: tetracaine, 
1.99 + 0.14; lidocaine, 2.30 + 0.11; procaine, 2.06 2 
0.34; dibucaine, 1.15 + 0.11; and aminoacridine, 1.04 + 
0.11 nmol . mg protein -I . min -I. At 0.1 mM tetracaine, 
lidocaine and procaine had no significant effect on the 
basal uptake. The basal uptake in the absence of any drug 
is 2.7 + 0.4 nmol . mg protein -* . min -i 
(see point designated ‘cant 37”‘). 
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Fig.2. The effect of various local anesthetics on the guanidinium uptake by hybrid cells stimulated by veratridine plus 
scorpion toxin: (A) control values of guanidinium uptake at 0°C and 37°C and the stimulation by veratridine (Vera, 0.2 
mM) and by veratridine + scorpion toxin (STX, 50 pg/ml); (B) the influence of local anesthetics on the guanidinium 
uptake stimulated by veratridine + scorpion toxin. The results shown are representative for 2 expt with similar results. 
dibucaine. Whereas tetracaine and procaine caused 
a small inhibition, lidocaine and benzocaine even at 
1 mM showed no significant effect. 
Strychnine blocked both the veratridine-stimu- 
lated and (to a moderate degree) the basal uptake of 
guanidinium in the hybrid cells (t&.3), the ZCso- 
values varying between 0.5-8 PM. Local an- 
esthetics and strychnine inhibited the guanidin- 
ium uptake similarly to the inhibitions seen in fig.1 
and 2, when the ion channel was activated by 
aconitine instead of veratridine (not shown). 
4. DISCUSSION 
Evidence has been presented here that in the 
hybrid and neuroblastoma cells the ion channel 
activated by veratridine is blocked by local anes- 
thetics. The potency of the local anesthetics tested 
varied considerably. The aromatic amine benzo- 
Caine, which is essentially uncharged at physiologi- 
cal pH, displayed no effect. The tertiary aliphatic 
amines carrying a positive charge at physiological 
pH showed increasing potencies in the sequence: 
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I 
Fig.3. Basal (curve a) and veratridine-stimulated (curve 
b) uptake of guanidinium in hybrid cells as a function of 
the concentration of strychnine. Similar results were ob- 
tained in 3 other expt. 
lidocaine < < procaine < tetracaine < dibucaine 
The extremely lipid-soluble local anesthetic di- 
bucaine (see in [3]) a tertiary aliphatic amine, turn- 
ed out to be the most potent local anesthetic in the 
experiments described. However, upon stimulation 
with veratridine + scorpion toxin, lidocaine and 
benzocaine block guanidinium uptake more po- 
tently than procaine. This could be due to a dif- 
ferent conformation of the ion channel, which is 
caused by the different modes of activation by 
veratridine or by veratridine + scorpion toxin. 
In the hybrid cells strychnine inhibited the vera- 
tridine-induced activation. An analogous obser- 
vation has been made in the frog node of Ranvier 
1221 and in the squid axon 1231, where strychnine 
inhibited the sodium conductance in a way com- 
parable to that for local anesthetics. The structural 
similarity of strychnine and lidocaine was indicated 
in 1231. We reported that propanolol blocked vera- 
tridine-activated guanidinium uptake in hybrid 
cells with lC50 60p.M [ 15,161 by a still unknown 
mechanism. Propanolol and other P-adrenoceptor 
blocking agents exert a substantial local anesthetic 
activity in several tissues (see (241). 
Models have been presented to describe the in- 
teraction of different local anesthetics with different 
sites on the sodium channel of neuroblastoma cells 
125,261. The hypothesis that local anesthetics act by 
‘chelating’ Ca ’ has been doubted (citations in [3]). 
However, local anesthetics have been found in bio- 
chemical and in electrophysiological studies to 
interfere with Ca*+-calmodulin-dependent 
processes as well as with Ca*+ channels 126,271. 
The mechanism of action of local anesthetics and 
anesthetic-like drugs on the voltage-dependent 
Na+ channel remains unclear. Further experiments 
yielding more information on the structure-activity 
relationship may help to distinguish between the 
possibilities that: 
(i) Local anesthetic drugs interfere with the vera- 
tridine binding site; 
(ii) Due to their charge, the drugs enter the ion 
channel and plug the pore, or they cause charge 
immobilization [ 281; 
(iii)Since local anesthetics are readily lipid-soluble, 
they indirectly affect the opening of sodium 
channels. 
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